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Xenotransplantation of porcine fetal ventral mesencephalic (pfVM) cells to overcome the dopamine shortage
in the striatum of patients with Parkinson’s disease seems a viable alternative to allotransplantion of human
fetal donor tissue, especially because the latter is complicated by both practical and ethical issues. There is,
however, little known about the xenospecific immune responses involved in such an intracerebral xenotrans-
plantation. The aim of our study was to investigate whether 1) naive human peripheral blood mononuclear
cells (PMBC) display cytotoxicity against pfVM cells of E28 pig fetuses, and 2) priming of human PBMC
by xenogeneic antigen presenting cells (APC) modulates pfVM-directed cellular cytotoxicity. For this pur-
pose fresh PMBC from nine individual donors were primed by incubation with either irradiated pfVM cells
or porcine spleen cells (PSC) as APC in the presence of IL-2 for 1 week before assessing cytotoxicity in a
51Cr release assay. Also, direct NK reactivity and antibody-dependent cellular cytotoxicity (ADCC) of fresh
PMBC against pfVM cells was assessed. No direct cytotoxicity of naive cells (either NK reactivity or
ADCC) against pfVM cells could be determined. Only PMBC primed with PSC were capable of lysing
pfVM cells. PBMC primed with pfVM cells did not show cytolytic capacity towards pfVM. Interestingly,
large differences in xenospecific T-cell responses exist between individual donor PBMC.Thus, human T
cells are capable of killing pfVM cells in a xenoreactive response, but only after priming by donor APC.
The large interindividual differences between human donors in their xenoreactive response may influence
patient selection for xenotransplantation and chances of graft survival for individual patients.
Key words: Xenotransplantation; Ventral mesencephalon; Parkinson’s disease; T cells;
Antibody-dependent cellular cytotoxicity (ADCC); Porcine
INTRODUCTION 14,44), little is known about immunological mechanisms
involved in intracerebral xenotransplantation.
Naturally occurring xenoreactive antibodies and com-A transplantation therapy using human fetal dopa-
minergic cells to substitute the shortage of dopamine in plement play an important role in the rejection of trans-
planted vascularized solid organs by initiating hyper-the striatum of patients suffering from Parkinson’s dis-
ease has been the subject of both experimental and clini- acute rejection (1,37); in a later stage, these factors may
play a central role in delayed xenograft rejection (2,38).cal investigation (6,17,26,35,36,42,50). Xenotransplan-
tation using porcine fetal ventral mesencephalic (pfVM) Although hyperacute rejection of porcine cell suspen-
sion grafts after transplantation is unlikely, in vivo stud-tissue is considered a viable alternative that addresses
shortage of human fetal tissue as well as a number of ies have shown that there is an important role for antibod-
ies and complement in the rejection of such intracerebralpractical and ethical issues involved in the use of human
fetal tissue (18,20,21,33). Although clinical trials using xenografts (4,5,24,28,29,48). Studies concerning the trans-
plantation of vascularized organs or pancreatic islets be-pfVM as a donor source have already taken place (10,
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yond species borders have shown that if hyperacute re- Trypsin Medium. The trypsin medium used was Ca2+
and Mg2+-free Hanks’s buffer, 0.6% glucose, 100 U/100jection has been overcome, mechanisms involving the
cellular compartment of the immune system are still ca- mg per ml penicillin/streptomycin, 0.3 mM/ml HEPES,
500 mg/ml DNAse, and 0.1% Worthington’s trypsin.pable of destroying the graft (9,23,27,43,51). The ques-
tion is whether these findings can be extrapolated to Trypsin Inhibiting Medium. The trypsin inhibiting
transplantation of fetal xenogeneic brain cells into a sup- medium used was Ca2+ and Mg2+-free Hank’s buffer so-
posedly immunoprivileged organ such as the brain. In lution, 500 mg/ml DNAse, 100 U/100 mg per ml peni-
vitro there is evidence of human T-cell reactivity (7) and cillin/streptomycin, 20% fetal calf serum (FCS), and 100
human NK reactivity (47) against pf brain cells. Also, mg/ml soybean trypsin inhibitor.
a role for host T cells in the rejection of intracerebral
Washing Medium. The washing medium used was
xenografts can be deducted from the beneficial effect of Ca2+ and Mg2+-free Hank’s buffer solution, 500 mg/ml
cyclosporin A (8) or blocking of swine leucocyte anti-
DNAse, 0.6% glucose, 100 U/100 mg per ml penicillin/gen (SLA) class I (11,34) on the survival of such a graft
streptomycin, 0.3 mM/ml HEPES with 10% or 20% FCS.in a xenogeneic animal model. Other in vivo studies pro-
Cryopreservation Medium. The cryopreservation me-vide further evidence of cellular mechanisms playing an
dium used was 0.9% saline, 0.6% glucose, and 10% di-important role in the rejection of intracerebral xenotrans-
methyl sulfoxide (DMSO) (AIM-V medium, Gibco).plantation (13,39).
With respect to this cell-mediated xenoreactivity, hu-
Preparation of pfVM and Porcine Spleen Cellsman lymphocytes may have the capacity to directly rec-
ognize and lyse pfVM cells through direct activity of Fetuses from 28 day pregnant cross-bred Dutch
Yorkshire Landrace pigs were obtained by hysterotomyNK cells, or antibody-dependent NK cell activity (ADCC),
as previously reported (47). Alternatively, xenograft and the VM was microscopically isolated and cut in 6–8
pieces (19,31,49). Half of the tissue fragments werecells could activate or “prime” human T cells. Priming
human lymphocytes for xenospecific cytolytic activity stored in 0.9% saline at 4°C for 2 h before being pro-
cessed into a single cell suspension; the other half wasis most effectively mediated by “professional” antigen
presenting cells (APC), such as macrophages or den- stored in a hibernation medium at 4°C for 44 h before
being cryopreserved (25).dritic cells. pfVM explants have been shown to contain
APC, which may lead to priming of human T cells as A single cell suspension was made incubating VM
tissue fragments in a trypsin medium for 15 min at 37°Cwas shown with macrophages that were selected by in
vitro culturing and were capable of inducing human T- and subsequent incubation in a trypsin inhibiting me-
dium for 5 min at room temperature. Subsequently, thecell proliferation (7). These data raise the question if
freshly isolated pfVM cells themselves are capable of tissue was rinsed three times using a 10% FCS-contain-
ing washing medium and gently dissociated using fire-priming human lymphocytes of different individuals for
xenospecific cytolytic activity and to what degree pfVM polished constricted Pasteur’s pipettes with decreasing
bore diameters. The number of viable cells was deter-cells are susceptible to cytolytic activity by human T
cells that were primed by “professional” xenogeneic mined by the trypan blue dye exclusion test, and viabil-
ity was expressed as percentage of viable cells with re-APC, such as spleen cells.
In this study we investigated direct in vitro reactivity spect to the total number of cells. Viability in this study
was used as quality control only; cell suspensions withof human peripheral blood mononuclear cells (PBMC)
of different donors against VM cells of E28 pig fetuses. viability lower than 90% were not used.
For cryopreservation, the hibernated tissue fragmentsFurthermore, we analyzed whether priming of human
PBMC with pfVM induces xenospecific cytolytic activ- were transferred to a 1-ml cryotube containing 1 ml of
cryopreservation medium and stored on melting ice be-ity and whether xenogeneic APC can enhance the ability
of PBMC to kill pfVM cells. fore being frozen in a programmed freezer using a freez-
ing program described previously (25,41) and stored inMATERIALS AND METHODS liquid nitrogen (−196°C) afterwards. To thaw the frozen
Reagents tissue fragments, the cryotube was placed in 37°C water
for 2 min. Subsequently the supernatant was slowly di-Hibernation Medium. The hibernation medium used
was 2.236 g/l KCl, 0.48 g/L MgCl2 × 6H2O, 0.9 g/L glu- luted with washing medium containing 20% FCS before
replacing the supernatant with washing medium to washcose, 0.89 g/L Na2HPO4 × 2H2O, 1.511 g/L NaH2PO4 ×
H2O, 6 ml/L lactic acid (30%, Sigma). The pH was set out DMSO before processing into a single cell suspen-
sion (25).at 7.2 by adding KOH, and osmolarity was adjusted to
300 mM by adding sorbitol (22). Porcine spleen was obtained from the same sow do-
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nating the fetuses to guarantee at least semi-identity in Statistics
MHC make up between spleen cells and pfVM. After Statistical analyses were performed using GraphPad
mechanical dissociation of pieces of porcine spleen tis- Prism version 3.00 for Windows (GraphPad Software,
sue, lymphocytes were derived using Lymfoprep (Axis- San Diego, CA, USA). To assess differences, the Wilco-
Shield PoC As) gradient centrifugation. Cells were ei- xon matched pairs test was performed.
ther used fresh or after cryopreservation using a standard RESULTSlymphocyte freezing program in a programmable freezer
pfVM Cells Are Lysed by Primed Human T Cellsand storing in liquid nitrogen until further use.
Human PMBC primed with porcine spleen cells
Isolation and Preparation of Human Serum showed a significant xenoreactive response against por-
and Peripheral Blood Mononuclear Cells (PBMC) cine VM cells in half of the individuals tested (Fig. 1B).
In contrast, cells primed by pfVM cells did not show aHuman PBMC from healthy volunteers were obtained
xenospecific response to pfVM (Fig. 1A). Differencesby Ficoll-Hyperque (Nycomed) gradient centrifugation.
were significant comparing human PMBC primed usingHuman serum was obtained from healthy donors and
PSC with human PMBC primed with pfVM or mediumheat inactivated before use.
control in their ability to lyse pfVM at an E:T ratio ofTo prime PBMC, fresh cells were incubated (1:1)
100:1 (p = 0.0117), 50:1 (p = 0.0117), and 12.5:1 (p =with 30 Gy irradiated pfVM cells or porcine spleen cells
0.0039) (Wilcoxon matched pairs test).as APC in serum-free AIM-V medium to which 15 U/
All donors lysed porcine spleen cells when primed byml IL-2 was added (37°C, 5% CO2). After 1 week cells
xenogeneic APC (spleen cells) (Fig. 1D), but not afterwere harvested and used in a cytotoxicity assay.
priming by pfVM cells (Fig. 1C). Differences were sig-
Determination of Cytotoxicity nificant comparing human PMBC primed using PSC
with human PMBC primed with pfVM or medium con-For measurement of PBMC activation and subse-
trol in their ability to lyse porcine spleen cells for all E:quent lysis of pfVM and porcine spleen cells we fol-
T ratios (p = 0.0039, Wilcoxon matched pairs test).lowed the protocol described by Yi et al. (51). PBMC
Although PMBC primed by xenogeneic APC lysedfrom nine individuals, either stimulated with adult por-
pfVM, porcine spleen cells were lysed more efficiently,cine spleen cells, pfVM cells, or medium were incubated
indicating that pfVM are poorly recognized (p = 0.0039at 37°C with thawed porcine spleen cells or thawed
for all E:T ratios, Wilcoxon matched pairs test).pfVM cells that were labeled with 51Cr (200 µCi). After
Loading of pfVM and spleen cells with 51Cr was4 h, 51Cr release was measured using a Packard gamma
comparable as demonstrated by comparable 51Cr releasecounter.
after addition of Triton 1% and background release. In-To determine direct NK cell-mediated cytotoxicity,
terestingly, large differences were observed in the de-freshly isolated human PBMC from six individuals were
gree of xenospecific lysis between PBMC of the differ-incubated at 37°C with 51Cr (200 µCi) labeled fresh
ent individuals tested (Fig. 1B, D).pfVM cells for 4 h with or without IL-2, before 51Cr
release was measured using a Packard gamma counter. No NK Cell-Mediated Cytotoxicity or ADCC to pfVM
To determine ADCC, fresh pfVM cells were labeled Human PBMC from six different individuals were
with 51Cr (200 µCi) and subsequently incubated at 37°C tested for NK reactivity against pfVM cells with andfor 30 min with heat-inactivated human serum. Serum
without IL-2 as additive to the medium. No NK cell-
was obtained from two donors that were known to pos-
mediated cytotoxicity could be determined in any of six
sess high levels of antibodies directed against pfVM. individuals tested, neither with nor without addition ofAfter rinsing three times with AIM-V medium and 2% IL-2 (Fig. 2; data not shown for testing without IL-2).human serum albumin, cells were incubated at 37°C In addition to direct NK cell activity, ADCC was as-
with PBMC from six human donors for 4 h. Subsequently,
sayed using serum from two individuals with high levels51Cr release was measured using a Packard gamma
of pfVM-specific antibodies and PBMC from six indi-
counter.
viduals. No ADCC reactivity could be determined (Fig.In all experiments Triton-X100 was added to deter- 3). Although cytotoxicity levels seemed to decrease with
mine maximum release and AIM-V medium to deter-
a lower E:T ratio, percentages of specific lysis were very
mine background release. The percentage specific lysis low and should be considered negative.
was calculated as the measured minus background re-
DISCUSSIONlease divided by the difference between maximum and
background. All measurements were performed in trip- In this study we show that porcine VM cells can be
targets for cytolytic activity by human xenoreactive Tlets. Data are expressed as mean values.
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Figure 1. Xenoreactive cytotoxicity of PBMC from nine individuals, stimulated by pfVM or PSC for 1 week, to either pfVM or
PSC. T = target cells and E = effector cells (human PMBC stimulated with either pfVM or PSC). The shaded areas represent the
control: PMBC that were cultured for 1 week without exposure to either pfVM or PSC and tested for specific lysis of pfVM (A,
B) or PSC (C, D). The height of the shaded area is defined by the individual with the highest specific lysis of either pfVM or PSC.
All measurements were performed in triplets and expressed as mean values. Intra-assay variability between triplets expressed as
standard deviation of the mean ranged from 0 to maximum 6.3% SD but was typically in the range of 1–2% SD.
cells, but only after they have been primed by xenoge- In the experiments we describe in this article, T-cell
activation is only possible via a direct route where donorneic APC. Without priming, human PBMC do not ap-
pear to show cytolytic activity towards xenogeneic pfVM APC activate human T cells. Cells that could function as
APC after intracerebral xenotransplantation and directlycells.
Both direct and indirect routes have been described activate host T cells are microglia, macrophages, and
possibly also astrocytes. Indeed, Brevig et al. havein which T cells can react with tissue antigens. After
xenotransplantation, xenoantigens have been found in shown that macrophages isolated from pfVM and cul-
tured in vitro upregulate MHC and are able to stimulatecervical lymph nodes of the recipient, suggesting indi-
rect antigen presentation (32). Also there is in vivo evi- T cells, as do isolated astrocytes, although not as effi-
ciently as do macrophages (7). However, in our experi-dence for a possible antigen presenting role of host mi-
croglia (15,16). Such an indirect route of T-cell activation ments pfVM appears to be a poor source of APC, be-
cause pfVM cells were not able to prime human PBMCmay well be very important in intracerebral pfVM trans-
plantation, because over 90% of the transplanted pfVM during in vitro coculture for a week. Furthermore, Duan
et al. have shown in an in vivo allogeneic transplantcells die within the first weeks of transplantation (3,46,
52). These dying pfVM cells could provide a substantial model that cotransplantation of spleen cells caused re-
jection of a neural graft (12). The above findings showantigenic load to host APC. Although transplanted
pfVM cells appear to die predominantly from apoptosis that stimulation of allogeneic and xenogeneic immune
responses is promoted by the presence of “professional”(30), and apoptotic cell clearance usually does not trig-
ger an immune response (40), Shrestha et al. have shown donor APC (expressing SLA class I and II). These data
also support our findings that a pfVM cell suspensionthat apoptotic cells can evoke both humoral and cellular
responses after transplantation (45). (with a low content of APC that could be considered
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with respect to individual cytotoxicity of human T cells
to pfVM and PSC may well reflect significant variations
in interindividual xenogeneic response patterns, possibly
genetically determined. Although speculative, these find-
ings could have significance for the clinical application
of xenotransplantation in Parkinson’s disease in terms
of patient selection and graft survival.
In our experiments we did not see any direct human
NK reactivity against pfVM cells in vitro, when testing
PBMC from different donors. Also, with IL-2-stimu-
lated human PBMC as effector cells no lysis was ob-
served. These findings seem to be in contrast with obser-
Figure 2. NK cell-mediated cytotoxicity of PMBC from six vations reported by Sumitran et al. using isolated human
individuals to pfVM cells in the presence of IL-2 as was ana- NK cells as effector cells. Sumitran et al. showed low
lyzed in a 51Cr release assay. All measurements were per-
reactivity by nonstimulated NK cells, but significant ly-formed in triplets and data are expressed as mean values. Intra-
sis of pfVM by IL-2-stimulated cells (47). It should beassay variability between triplets expressed as standard devia-
noted, however, that both duration and concentration oftion of the mean ranged from 0 to maximum 13.3% SD.
the IL-2 treatment differed significantly between Sumi-
tran’s and our experiments. Moreover, Sumitran et al
used a preparation of isolated human NK cells. This
probably also explains why they were able to measureprofessional APC) is a rather poor stimulator of a xeno-
up to 60% lysis at an E/T ratio of 30:1, whereas in ourspecific T-cell response. This is in contrast to porcine
experiments no direct cytotoxicity was found, even at anspleen cells, which were able to stimulate T cells from
E/T ratio of 100:1, at which it is likely that a fair amountdifferent human donors quite effectively. Once stimu-
of NK cells must have been present. Nevertheless, thislated by porcine spleen cells, human T cells do recog-
finding again stresses that without additional priming,nize and lyse pfVM cells. Interestingly, marked differ-
existing reactivity among human PBMC against xenoge-ences were observed between cytotoxicity of stimulated
neic pfVM cells is extremely low.T cells from different human donors to both pfVM and
As with direct NK reactivity, we also did not observeporcine spleen cells. Because pfVM and PSC cells were
any cytotoxicity in the presence of heat-inactivated hu-isolated from non-inbred pigs, we used the sow that do-
man serum. This finding seems to indicate that humannated the fetuses as a source of spleen cells and used
NK cell-mediated ADCC to pfVM cells is also virtuallycryopreserved pfVM and PSC from the same harvest as
absent in human PBMC and is well in line with ourfresh stimulator cells as target cells. These measures
previous findings that only minimal amounts of pfVM-were made to limit differences in MHC make up be-
specific antibody for facilitation of ADCC (i.e., IgG sub-tween pfVM and PSC, but also between stimulator cells
type antibodies) are present in human serum (24).and target cells. Therefore, the differences we observed
Figure 3. ADCC reactivity of PBMC from six individuals to pfVM cells that were incubated with human serum prior to a 51Cr
release assay. (A, B) Results after incubation with serum from the two individuals known to possess high levels of antibodies with
affinity for pfVM. All measurements were performed in triplets and data are expressed as mean values. Intra-assay variability
between triplets expressed as standard deviation of the mean ranged from 0 to maximum 9.6% SD.
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